每年研究成果
每年研究成果
- 18結果
搜尋結果
-
2022
Minimizing nephrotoxicity during multidrug-resistant tuberculosis treatment by the stepwise de-escalation of second-line injectables dosing intervals
Lin, H. C., Yu, M. C., Putri, D. U., Tsai, Y. S., Chen, J. H. & Lee, C. H., 5月 2022, 於: Clinical Microbiology and Infection. 28, 5, p. 752-754 3 p.研究成果: 雜誌貢獻 › 快報 › 同行評審
開啟存取 -
2021
Acute generalized exanthematous pustulosis induced by atezolizumab in a patient with lung adenocarcinoma
Chang, H. C., Ko, P. H., Chang, Y. S. & Chou, P. C., 9月 2021, 於: Lung Cancer. 159, p. 175-176 2 p.研究成果: 雜誌貢獻 › 快報 › 同行評審
2 引文 斯高帕斯（Scopus） -
Higher alveolar deposition of particulate matter in emphysematous lobes of COPD
Tung, N. T., Ho, S. C., Lu, Y. H., Chen, T. T., Lee, K. Y., Chen, K. Y., Wu, C. D., Chung, K. F., Kuo, H. P., Thao, H. N. X., Dung, H. B., Thuy, T. P. C., Wu, S. M., Kou, H. Y., Lee, Y. L. & Chuang, H. C., 2021, 於: ERJ Open Research. 7, 3, 00324-2021.研究成果: 雜誌貢獻 › 快報 › 同行評審
開啟存取3 引文 斯高帕斯（Scopus） -
N−3 fatty acid supplementation in asthma management: A systematic review and meta-analysis
Wang, Y. H., Huang, S. Y., Kuo, H. P., Fan, H. Y., Moreira, A., Papamichael, M. M. & Chen, Y. C., 11月 2021, 於: Allergy: European Journal of Allergy and Clinical Immunology. 76, 11, p. 3042-3046 5 p.研究成果: 雜誌貢獻 › 快報 › 同行評審
-
Particulate matter and SARS-CoV-2: A possible model of COVID-19 transmission
Tung, N. T., Cheng, P. C., Chi, K. H., Hsiao, T. C., Jones, T., BéruBé, K., Ho, K. F. & Chuang, H. C., 1月 1 2021, 於: Science of the Total Environment. 750, 141532.研究成果: 雜誌貢獻 › 快報 › 同行評審
49 引文 斯高帕斯（Scopus） -
2020
COVID-19: An aerosol’s point of view from expiration to transmission to viral-mechanism
Hsiao, T. C., Chuang, H. C., Griffith, S. M., Chen, S. J. & Young, L. H., 5月 2020, 於: Aerosol and Air Quality Research. 20, 5, p. 905-910 6 p.研究成果: 雜誌貢獻 › 快報 › 同行評審
開啟存取35 引文 斯高帕斯（Scopus） -
New diseases and old threats: Lessons from tuberculosis for the COVID-19 response
Dara, M., Sotgiu, G., Reichler, Chiang, C. Y., Chee, C. B. E. & Migliori, G. B., 5月 1 2020, 於: International Journal of Tuberculosis and Lung Disease. 24, 5, p. 544-545 2 p.研究成果: 雜誌貢獻 › 快報 › 同行評審
39 引文 斯高帕斯（Scopus） -
Tackling the threat of COVID-19 in Africa: An urgent need for practical planning
Chiang, C. Y. & Sony, A. E., 5月 1 2020, 於: International Journal of Tuberculosis and Lung Disease. 24, 5, p. 541-542 2 p.研究成果: 雜誌貢獻 › 快報 › 同行評審
18 引文 斯高帕斯（Scopus） -
The impact of COVID-19 and the restoration of tuberculosis services in the Western Pacific Region
Chiang, C. Y., Islam, T., Xu, C., Chinnayah, T., Garfin, A. M. C., Rahevar, K. & Raviglione, M., 2020, 於: European Respiratory Journal. 56, 4, 2003054.研究成果: 雜誌貢獻 › 快報 › 同行評審
開啟存取15 引文 斯高帕斯（Scopus） -
The impact of smoking on TB treatment outcomes includes recurrent TB
Chiang, C. Y. & Bam, T. S., 11月 1 2020, 於: International Journal of Tuberculosis and Lung Disease. 24, 11, p. 1224-1225 2 p.研究成果: 雜誌貢獻 › 快報 › 同行評審
3 引文 斯高帕斯（Scopus） -
2019
Prognostic factors and first-line treatment modalities in nonagenarian patients with lung cancer
Hsu, C. C., Huang, Y. T., Tseng, Y. H., Luo, Y. H. & Chen, Y. M., 5月 1 2019, 於: Journal of Geriatric Oncology. 10, 3, p. 439-441 3 p.研究成果: 雜誌貢獻 › 快報 › 同行評審
-
Tolerability of rifapentine-based regimens in latent tuberculosis infection treatment in the elderly
Chan, P. C., Lee, P. H., Lu, M. J., Huang, Y. C., Feng, T. Y., Chen, W. W., Lee, C. C., Huang, Y. F. & Chiang, C. Y., 3月 1 2019, 於: The European respiratory journal. 53, 3, 1802396.研究成果: 雜誌貢獻 › 快報 › 同行評審
開啟存取2 引文 斯高帕斯（Scopus） -
2017
Gefitinib or erlotinib for previously treated lung adenocarcinoma: Which is superior?
Chang, C. H., Lee, C. H. & Wang, J. Y., 4月 20 2017, 於: Journal of Clinical Oncology. 35, 12, p. 1374 1 p.研究成果: 雜誌貢獻 › 快報 › 同行評審
3 引文 斯高帕斯（Scopus） -
Shortened multidrug-resistant tuberculosis regimens overcome low-level fluoroquinolone resistance
Van Deun, A. & Chiang, C. Y., 6月 1 2017, 於: European Respiratory Journal. 49, 6, 1700223.研究成果: 雜誌貢獻 › 快報 › 同行評審
16 引文 斯高帕斯（Scopus） -
Tuberculosis contact investigation in an intermediate burden setting: implications from a large tuberculosis contact cohort in Taiwan
Lee, M. R., Ho, C. M., Lee, C. H., Lee, M. C., Chang, L. Y., Yu, K. L., Ko, J. C., Wang, J. Y., Wang, J. T. & Lee, L. N., 8月 1 2017, 於: The European respiratory journal. 50, 2研究成果: 雜誌貢獻 › 快報 › 同行評審
11 引文 斯高帕斯（Scopus） -
2015
An integrated MDR-TB management programme results in favourable outcomes in northern Taiwan
Yu, M. C., Chen, H. Y., Chien, S. H. & Jou, R., 1月 1 2015, 於: European Respiratory Journal. 45, 1, p. 272-275 4 p.研究成果: 雜誌貢獻 › 快報 › 同行評審
8 引文 斯高帕斯（Scopus） -
Coinfection of Pneumocystis jiroveci pneumonia and pulmonary tuberculosis in a non-HIV-infected patient
Suk, C. W., Bai, K-J., Yu, M-C. & Hu, T. Y., 12月 1 2015, 於: Journal of Microbiology, Immunology and Infection. 48, 6, p. 711-712 2 p.研究成果: 雜誌貢獻 › 快報 › 同行評審
2 引文 斯高帕斯（Scopus） -
2009
Weekly cetuximab and gemcitabine plus cisplatin as salvage therapy for unresectable non-small cell lung cancer
Tai, C. J., Hsu, C. H., Wang, F. J., Chau, W. K., Chung, C. L. & Hsieh, C. C., 11月 2009, 於: Onkologie. 32, 11, p. 685-686 2 p.研究成果: 雜誌貢獻 › 快報 › 同行評審